- Home
- MSGM vs MBRX Comparison
MSGM vs MBRX Comparison
Compare MSGM & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSGM | MBRX |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4M | 13.1M |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MSGM | MBRX |
|---|---|---|
| Price | $4.30 | $2.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $61.00 |
| AVG Volume (30 Days) | 47.2K | ★ 227.1K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 252.13 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $741,000.00 | N/A |
| Revenue This Year | $69.73 | N/A |
| Revenue Next Year | $146.81 | N/A |
| P/E Ratio | $72.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.11 | $0.25 |
| 52 Week High | $5.78 | $7.98 |
Technical Indicators
Market Signals| Indicator | MSGM | MBRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 59.86 |
| Support Level | $3.95 | $2.27 |
| Resistance Level | $4.57 | $2.95 |
| Average True Range (ATR) | 0.22 | 0.22 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 63.64 | 63.11 |
Price Performance
Historical ComparisonAbout MSGM Motorsport Games Inc.
Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.